Effective Real-World Evidence for Adding Value to a Clinical Trial

Pharmaceutical Executive June 30, 2025
Ed Schoonveld, Edward Ahn, Shana Gunderson Hua, PharmD, Rob Philo

In response to the rising importance of real-world evidence (RWE) in showing value to payers beyond traditional clinical trials, key opinion leaders emphasize finding cost-effective approaches, considering diverse patient populations, and using AI to pinpoint which patients will benefit most from treatment.

Real-world evidence (RWE) is no longer optional—it’s expected. This episode dives into how payers assess RWE alongside clinical trial data, especially in competitive therapeutic areas. The panel stresses the...

Today's Sponsors

Today's Sponsor